REMEDY KOMPLEMENTAR APS: Financial statements 2025
CVR: 43993577
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
REMEDY KOMPLEMENTAR APS (CVR 43993577) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 3,852 and a net result of DKK 2,682 compared with DKK 1,377 the year before. That is an increase of 242.4% compared with the year before. Equity in the 2025 report amounted to DKK 43,800. The solvency ratio was 82.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 3,852
- Profit/Loss
- DKK 2,682
- Equity
- DKK 43,800
- Total Assets
- DKK 53,199
- Employees
- 1
Official annual report
How creditworthy is REMEDY KOMPLEMENTAR APS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
REMEDY KOMPLEMENTAR APS has published its annual report for 2024. Revenue came to DKK 0, and the net result was DKK 1,377.
About REMEDY KOMPLEMENTAR APS
REMEDY KOMPLEMENTAR APS is a Danish company of the type Anpartsselskab based in Ry, founded in 2023. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Karsten Fjordside Poulsen, Mikkel Mirsbach Rasmussen and Steffen Ulsø Knudsen. The company is owned by Steffen Ulsø Knudsen, Karsten Fjordside Poulsen and Mikkel Mirsbach Rasmussen. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 3,852 and a net result of DKK 2,682 compared with DKK 1,377 the year before. Equity in the 2025 report amounted to DKK 43,800.